Compare TG Therapeutics Inc (TGTX) vs WD 40 Company (WDFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs WD 40 Company — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while WD 40 Company trades at $237.72 (market cap $3.22B). The key difference: TG Therapeutics Inc is far larger — about 2.6× WD 40 Company's market cap, and WD 40 Company pays a 1.7% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WDFC | |
|---|---|---|
Market Cap | $8.26B | $3.22B |
Sector | Health | Technology |
52-Week High | $59.06 | $264.91 |
52-Week Low | $26.39 | $187.52 |
Enterprise Value | $8.50B | $3.27B |
Dividend Yield | — | 1.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →
